Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (671-680 of 999) with videos related to

Pageof 100
Sort By:
European Heart Journal|July 27, 2013
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
Journal of the American Geriatrics Society|September 13, 2024
Association of left atrial function with frailty: The Atherosclerosis Risk in Communities (ARIC) studyDaokun Sun, Romil R Parikh, Wendy Wang, et al.
Eclinicalmedicine|September 10, 2021
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysisSafi U Khan, Ahmad N Lone, Muhammad Shahzeb Khan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 3, 2022
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief ReportMatthew R Deshotels, Trevor D Hadley, Mendel Roth, et al.
Circulation. Cardiovascular Genetics|November 19, 2015
Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEADL Maria Belalcazar, George D Papandonatos, Bahar Erar, et al.
Atherosclerosis|June 23, 2017
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURNRishi Puri, Christie M Ballantyne, Ron C Hoogeveen, et al.
Clinical Chemistry|April 2, 2025
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human PlasmaMary R Rooney, Jingsha Chen, Christie M Ballantyne, et al.
Atherosclerosis|August 9, 2014
Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League playersYashashwi Pokharel, Vijay Nambi, Seth S Martin, et al.
Atherosclerosis|November 24, 2017
Lipoprotein-associated phospholipase A<sub>2</sub> and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC)Parveen K Garg, Faye L Norby, Linda M Polfus, et al.
Journal of Clinical Lipidology|March 25, 2023
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive CardiologySalim S Virani, Karen Aspry, Dave L Dixon, et al.
Pageof 100

Showing results (671-680 of 999) with videos related to

Sort By:
Pageof 100
European Heart Journal|July 27, 2013
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyRishi Puri, Steven E Nissen, Mingyuan Shao, et al.
Journal of the American Geriatrics Society|September 13, 2024
Association of left atrial function with frailty: The Atherosclerosis Risk in Communities (ARIC) studyDaokun Sun, Romil R Parikh, Wendy Wang, et al.
Eclinicalmedicine|September 10, 2021
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysisSafi U Khan, Ahmad N Lone, Muhammad Shahzeb Khan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 3, 2022
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief ReportMatthew R Deshotels, Trevor D Hadley, Mendel Roth, et al.
Circulation. Cardiovascular Genetics|November 19, 2015
Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEADL Maria Belalcazar, George D Papandonatos, Bahar Erar, et al.
Atherosclerosis|June 23, 2017
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURNRishi Puri, Christie M Ballantyne, Ron C Hoogeveen, et al.
Clinical Chemistry|April 2, 2025
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human PlasmaMary R Rooney, Jingsha Chen, Christie M Ballantyne, et al.
Atherosclerosis|August 9, 2014
Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League playersYashashwi Pokharel, Vijay Nambi, Seth S Martin, et al.
Atherosclerosis|November 24, 2017
Lipoprotein-associated phospholipase A<sub>2</sub> and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC)Parveen K Garg, Faye L Norby, Linda M Polfus, et al.
Journal of Clinical Lipidology|March 25, 2023
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive CardiologySalim S Virani, Karen Aspry, Dave L Dixon, et al.
Pageof 100